comparemela.com

Latest Breaking News On - Chief executive brian goff - Page 1 : comparemela.com

Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal

Agios agreed Tuesday to sell its 15% royalty in a brain cancer drug for $905 million upfront. Agios stock broke out at the open.

Brian-goff
Agios-pharmaceuticals
Drug-administration
Royalty-pharma
Chief-executive-brian-goff

vimarsana © 2020. All Rights Reserved.